Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06618534
PHASE2
Azithromycin for Meningococcal Carriage
Sponsor: Emory University
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine the effectiveness of azithromycin in the eradication of nasopharyngeal carriage of N. meningitidis
Official title: Effectiveness of Azithromycin in Eradicating Nasopharyngeal Carriage of N. Meningitidis
Key Details
Gender
All
Age Range
18 Years - 25 Years
Study Type
INTERVENTIONAL
Enrollment
1120
Start Date
2024-11-12
Completion Date
2026-05
Last Updated
2025-11-10
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Azithromycin
A standard dose of azithromycin (500 mg) will be delivered by oral route.
Locations (1)
Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, United States